|

Dose 1 YN001 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Beijing Inno Medicine Co., Ltd.1

Indications

  • Coronary Atherosclerotic Disease1
  • Heart Disease1
  • Coronary Artery Disease1

Other1 trial

YN001-004 in Patients With Coronary Atherosclerosis in Australia
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.